QUESTION: The study shows that compound 6j has strong antibacterial activity and low cytotoxicity, but it does not explain how the addition of the thioguanine unit specifically alters binding interactions at the ribosome compared to existing drugs. How does the presence of the thioguanine moiety change the molecular mechanism of inhibition at the 50S ribosomal subunit relative to other pleuromutilin derivatives?

CONNECT: The nucleophilic substitution used to attach thioguanine to the activated pleuromutilin intermediate directly relates to SN2 reactions studied in organic chemistry. The tosylate group acts as a good leaving group, allowing the thioguanine nucleophile to attack the electrophilic carbon. This is consistent with the principle that better leaving groups increase reaction efficiency and yield.

FACT: The synthesis begins by converting the C-22 hydroxyl group of pleuromutilin into a better leaving group using p-toluenesulfonyl chloride, forming an intermediate that undergoes nucleophilic substitution with 6-thioguanine. This reaction forms a new C–S bond (thioether linkage), which is important because thioether groups are known to enhance antibacterial activity in pleuromutilin derivatives.